Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Sakai

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|March 2, 2011
["Molecular-targeting prevention" of cancer. The theory and its possibilities]Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|April 3, 2020
[Generalized spinal cord atrophy and oligoclonal IgG band in the cerebrospinal fluid due to chronic toluene intoxication: a case report]Toshiyuki Sakai
Pharmacology & Therapeutics|June 22, 2022
"RB-reactivator screening" as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist)Toshiyuki Sakai
Environmental Health and Preventive Medicine|March 25, 2011
INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancerYouichirou Matsuzaki, Toshiyuki Sakai
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|June 17, 2003
[Gene-regulating chemoprevention against cancer--as a model for "molecular-targeting prevention" of cancer]Yoshihiro Sowa, Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|July 30, 2003
[Regional cerebral blood flow measured by three-dimensional stereotactic surface projections (3D-SSP) of 123I-IMP SPECT in Parkinson disease patients with cognitive impairment]Toshiyuki Sakai, Shigeki Kuzuhara
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Ras/Raf/MEK/ERK cascade]Yoshihiro Sowa, Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|April 20, 2006
[Diffusion-weighted magnetic resonance imagings at the acute stage in two patients with spectacular shrinking deficit due to cardioembolic stroke]Toshiyuki Sakai, Shigeki Kuzuhara
Vitamins and Hormones|April 28, 2004
Promoter of TRAIL-R2 geneTatsushi Yoshida, Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|October 16, 2012
[Neuroimaging of a 39-year-old woman with transient global amnesia accompanied by cerebral venous reflow abnormalities]Toshiyuki Sakai, Hidekazu Tomimoto
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|March 2, 2011
["Molecular-targeting prevention" of cancer. The theory and its possibilities]Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|April 3, 2020
[Generalized spinal cord atrophy and oligoclonal IgG band in the cerebrospinal fluid due to chronic toluene intoxication: a case report]Toshiyuki Sakai
Pharmacology & Therapeutics|June 22, 2022
"RB-reactivator screening" as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist)Toshiyuki Sakai
Environmental Health and Preventive Medicine|March 25, 2011
INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancerYouichirou Matsuzaki, Toshiyuki Sakai
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|June 17, 2003
[Gene-regulating chemoprevention against cancer--as a model for "molecular-targeting prevention" of cancer]Yoshihiro Sowa, Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|July 30, 2003
[Regional cerebral blood flow measured by three-dimensional stereotactic surface projections (3D-SSP) of 123I-IMP SPECT in Parkinson disease patients with cognitive impairment]Toshiyuki Sakai, Shigeki Kuzuhara
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Ras/Raf/MEK/ERK cascade]Yoshihiro Sowa, Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|April 20, 2006
[Diffusion-weighted magnetic resonance imagings at the acute stage in two patients with spectacular shrinking deficit due to cardioembolic stroke]Toshiyuki Sakai, Shigeki Kuzuhara
Vitamins and Hormones|April 28, 2004
Promoter of TRAIL-R2 geneTatsushi Yoshida, Toshiyuki Sakai
Rinsho Shinkeigaku = Clinical Neurology|October 16, 2012
[Neuroimaging of a 39-year-old woman with transient global amnesia accompanied by cerebral venous reflow abnormalities]Toshiyuki Sakai, Hidekazu Tomimoto
Pageof 27